minami takafumi 南高文

… Alternative Names

MINAMI Takafumi 南高文

Less

Researcher Number	70340809
Other IDs
Affiliation (Current)	2025: 近畿大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2023 – 2024: 近畿大学, 医学部, 准教授 2013 – 2022: 近畿大学, 医学部, 講師 2007 – 2013: 近畿大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Urology Except Principal Investigator Urology / Basic Section 56030:Urology-related
Keywords	Principal Investigator ペプチドワクチン / 前立腺癌 / HLA-A3 supertype alleles / HLA-A3 / 癌ワクチン / EZH2 / テーラーメイド / 潜伏感染 / alleles / supertype … More Except Principal Investigator … More ペプチドワクチン / 腎細胞癌 / 免疫療法 / EPOR / バイオマーカー / 複合免疫療法 / PDL-1 / HIF-1 / 癌ワクチン療法 / 腎細胞がん / 癌ワクチン / VEGFR / CA9 / HLA-A2 / がんワクチン / HLA-A24 / ワクチン療法 / ペプチド / CA9抗原 / PDL / HIF-1α / ペプチドワクチン療法 / 腎癌 Less

腎細胞がんに対する癌ワクチンを用いた複合免疫療法の有用性に関する検討
- Principal Investigator
  
  植村天受
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kindai University
Development of combination immunotherapy with peptide vaccines for renal cell carcinoma.
- Principal Investigator
  
  Uemura Hirotsugu
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kindai University
Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Identification of peptides which can be applied to cancer vaccine therapy for patients with prostate cancerPrincipal Investigator
- Principal Investigator
  
  MINAMI Takafumi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Development of multi-peptide tumor vaccine for renal cell carcinoma
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patientsPrincipal Investigator
- Principal Investigator
  
  MINAMI Takafumi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of tailor made peptide vaccines for renal cell carcinoma
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patients研究代表者南高文(MINAMI TAKAFUMI)Principal Investigator
- Principal Investigator
  
  MINAMI Takafumi
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patientsPrincipal Investigator
- Principal Investigator
  
  MINAMI Takafumi
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of tailor-madepeptide vaccines for renal eell carcinoma
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University

All 2021 2017 2016 2015 2014 2013 2012 2008 2007 Other

All Journal Article Presentation Patent

[Journal Article] T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma2021
- Author(s)
  Harada Mamoru、Iida Yuichi、Kotani Hitoshi、Minami Takafumi、Komohara Yoshihiro、Eto Masatoshi、Yoshikawa Kazuhiro、Uemura Hirotsugu
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 71 Issue: 2 Pages: 339-352
- DOI
  10.1007/s00262-021-02992-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-19H03794, KAKENHI-PROJECT-21K07177
[Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017
- Author(s)
  1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 44 Pages: 197-202
- DOI
  10.1016/j.intimp.2017.01.014
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
[Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015
- Author(s)
  Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
- Journal Title
  
  Journal of Immunotherapy
  
  Volume: 38 (7) Issue: 7 Pages: 285-291
- DOI
  10.1097/cji.0000000000000090
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles.2015
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco MA, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 26(1) Pages: 133-138
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10612
[Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  International Immunopharmacology
  
  Volume: 26 Issue: 1 Pages: 133-138
- DOI
  10.1016/j.intimp.2015.03.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] Transfection of poly(I:C) can induce ROS-triggered apoptosis and IFN--mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system2014
- Author(s)
  Harashima N, Minami T, Uemura H, Harada M
- Journal Title
  
  Molecular Cancer
  
  Volume: 13 Issue: 1 Pages: 217-217
- DOI
  10.1186/1476-4598-13-217
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25293336, KAKENHI-PROJECT-25430150
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H.
- Journal Title
  
  Br J Cancer.
  
  Volume: 108 Issue: 6 Pages: 1260-1266
- DOI
  10.1038/bjc.2013.90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H
- Journal Title
  
  Br J Cancer
  
  Volume: 108(6) Pages: 1260-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Phase I/II study of individualized peptide vaccines for HLA-A2/24 positive patients with hormone-refractory prostate cancer2008
- Author(s)
  Uemura H., Minami T., Tanaka M, 他4名
- Journal Title
  
  J. Clin. Oncol. 26
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Idenitification of SART3-derived peptides having the potential to induce cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T., Uemura H., Harada M, 他5名
- Journal Title
  
  Cancer Immunol.Immunother 56
  
  Pages: 689-698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Patent] HLA-A24分子に結合でき、かつ細胞性免疫に認識されるHIF-1α由来ペプチド、及びそれを含む腎細胞癌ワクチン2016
- Inventor(s)
  植村天受、南高文
- Industrial Property Rights Holder
  植村天受、南高文
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2016-209180
- Filing Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-16H05466
[Presentation] HLA-A24陽性腎細胞癌症例においてCancer-reactive cytotoxic T lymphocytes を誘導しうるEpoR, PD-L1ペプチドの同定2016
- Author(s)
  南　高文、南　知子、清水信貴、山本　豊、Marco De Velasco、野澤昌弘、吉村一宏、
- Organizer
  第104回日本泌尿器科学会総会
- Place of Presentation
  仙台国際センター、東北大学記念会館、仙台市
- Year and Date
  2016-04-23
- Data Source
  KAKENHI-PROJECT-16H05466
[Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013
- Author(s)
  T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
- Organizer
  28th Annual EAU Congress
- Place of Presentation
  Milan
- Year and Date
  2013-03-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012
- Author(s)
  南高文、南知子、大関孝之、デベラスコマルコ、清水信貴、山本豊、辻秀憲、野澤昌弘、吉村一宏、植村天受
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012
- Author(s)
  植村天受、吉村一宏、南高文、デベラスコマルコ
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012
- Author(s)
  Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
- Organizer
  The 10th Annual Meeting of Japanese Society of Medical Oncology
- Place of Presentation
  Osaka
- Year and Date
  2012-07-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] HLA-A24陽性腎細胞癌患者におけるcancer-rective CTLsを誘導し得るEpoR抗原由来ペプチドの同定
- Author(s)
  南　高文、植村天受ほか
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌（札幌市）
- Data Source
  KAKENHI-PROJECT-22390305

1. UEMURA Hirotsugu (90213397)

# of Collaborated Projects: 7 results

# of Collaborated Products: 12 results
2. DE VELASCO Marco (20449838)

# of Collaborated Projects: 5 results

# of Collaborated Products: 7 results
3. HARADA Mamoru (50260716)

# of Collaborated Projects: 5 results

# of Collaborated Products: 5 results
4. YOSHIMURA Kazuhiro (20283757)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
5. TANAKA Motoyoshi (30347562)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. NOZAWA Masahiro (00441080)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. UEJIMA Shigeya (60213336)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. KOTANI Hitoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 原嶋奈々江

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

minami takafumi 南 高文

MINAMI Takafumi 南 高文

Research Projects

Research Products

Co-Researchers

腎細胞がんに対する癌ワクチンを用いた複合免疫療法の有用性に関する検討

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of combination immunotherapy with peptide vaccines for renal cell carcinoma.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of peptides which can be applied to cancer vaccine therapy for patients with prostate cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of multi-peptide tumor vaccine for renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of tailor made peptide vaccines for renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patients研究代表者南高文(MINAMI TAKAFUMI)Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of tailor-madepeptide vaccines for renal eell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015

Author(s)

Journal Title

DOI

Data Source

minami takafumi 南高文

MINAMI Takafumi 南高文

[Journal Article] Transfection of poly(I:C) can induce ROS-triggered apoptosis and IFN--mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system2014